Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Correction: The role of corticosteroids in severe community-acquired pneumonia: a systematic review. | Available online http content 12 6 434 Correction Correction The role of corticosteroids in severe community-acquired pneumonia a systematic review Jorge IF Salluh1 2 Pedro Póvoa3 Márcio Soares1 Hugo C Castro-Faria-Neto2 Fernando A Bozza4 and Patricia T Bozza2 11ntensive Care Unit Instituto Nacional de Câncer Praọa Cruz Vermelha 23 10 andar - Centro Rio de Janeiro-RJ Brazil 20230-130 2Immunopharmacology Laboratory Instituto Oswaldo Cruz FIOCRUZ Av. Brasil 4365 Rio de Janeiro-RJ Brazil 21045-900 3Medical Intensive Care Unit Hospital de São Francisco Xavier. Centro Hospitalar de Lisboa Ocidental Estrada do Forte do Alto do Duque CEP 1449-005 Lisboa Portugal 4Instituto de Pesquisa Clinica Evandro Chagas Fundaọão Oswaldo Cruz Av. Brasil 4365 Rio de Janeiro-RJ Brazil 21045-900 Corresponding author Jorge IF Salluh jorgesalluh@ Published 7 November 2008 This article is online at http content 12 6 434 2008 BioMed Central Ltd Critical Care 2008 12 434 doi cc7107 Following the publication of the above article 1 we noticed that in Table 1 concerning the data of the study from Garcia-Vidal the dose of methylprednisolone is not mg day but 45 mg day. Reference 1. Salluh JI Povoa P Soares M Castro-Faria-Neto HC Bozza FA Bozza PT The role of corticosteroids in severe community-acquired pneumonia a systematic review. Crit Care 2008 12 R76. Competing interests The author s declare that they have no competing interests. Table 1 Recent literature on the role of corticosteroids in severe community-acquired pneumonia Reference Study design Sample size number Patient selection Corticosteroids drug regimen Primary endpoints Level of evidence and recommendation Marik et al. 21 Single-center RCT 30 Severe CAP Hydrocortisone 10 mg kg versus placebo 30 minutes before antibiotics Mortality clinical course and serum TNF-a levels Weak recommendation moderate-quality evidence Confalonieri et al. 6 Multicenter RCT 46 Severe CAP Hydrocortisone 200 mg
